Broadline Capital
Overview
Broadline Capital is a global alternative investment firm focused primarily on growth capital and late-stage ventures. Founded over two decades ago by Chris Thorne, the firm has developed a history of investing in category leaders and category creators that are helping to re-shape their industry . The firm seeks to invest in companies positioned to create broad impact as the world transitions toward technology transformation and the pursuit of a more efficient, sustainable, and healthy life .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EndoSphere | Apr 2012 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Broadline Capital based?
Broadline Capital is headquartered in New York City, New York, United States.
When was Broadline Capital founded?
Broadline Capital was founded in 2005.
How many portfolio companies does Broadline Capital have?
Broadline Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Broadline Capital's portfolio?
Portfolio companies visible on Caplight include EndoSphere.
What was Broadline Capital's most recent investment shown here?
Broadline Capital's most recent investment in this portfolio sample was in EndoSphere in 2012.
What sectors does Broadline Capital focus on?
Broadline Capital focuses on Healthcare & Life Sciences.
What company stages does Broadline Capital focus on?
Broadline Capital typically invests at the Early stage.